Crestor Kidney Failure
Since 2003, at least twenty seven people have reported Crestor kidney failure from regular use of this prescription medication. Reports of Crestor kidney failure first began before this statin cholesterol drug was ever approved for use in the United States. At least seven cases of Crestor kidney failure were known to the Food and Drug Administration and the makers of Crestor (AstraZeneca) before this drug was approved in August 2003. The FDA did not approve Crestor in stronger proposed doses because of serious Crestor kidney failure risks.
Information about Crestor kidney failure risks followed the recall of a similar medication that posed the same serious risks to its users. Baycol, manufactured by Bayer, was pulled off the shelves in 2001 after a series of studies linked regular use of this drug with serious side effects including kidney failure. Though studies have found similar risks to patients taking Crestor, AstraZeneca has made no effort to protect patients from Crestor kidney failure and other serious side effects.
Crestor Drug Recall
Prominent consumer advocacy groups like Public Citizen have repeatedly urged the FDA to order a recall of Crestor in order to protect patients from Crestor kidney failure. Their studies have shown that the rate of serious side effects is 75 times greater with Crestor use compared to the use of similar drugs. Similar drugs have also shown to protect against stroke and heart attack, whereas Crestor use has no such benefits. Because of the obvious risks of Crestor, consumer watchdogs feel that keeping Crestor on the market poses an enormous threat to consumer health.
Crestor kidney failure is often the result of another condition called Rhabdomyolysis. Rhabdomyolysis is an acute, rapidly-developing disease that destroys skeletal muscles. As these muscles atrophy, they release their contents, potassium and myoglobin, into the blood stream. This can lead to hypovolemia and hyperalemia, two conditions that cause a dangerous imbalance in blood constituent levels. When this blood reaches the kidneys, it acts as a toxin which can lead to renal injury and Crestor kidney failure.
The kidneys are responsible for excreting waste and maintaining necessary electrolyte balance in the body. When a person suffers from Crestor kidney pain, their kidneys are no longer able to perform this function and serious injury or death can result. Some of the earliest symptoms of rhabdomyolysis include: muscle weakness or fatigue, dark urine, weight gain, seizures, joint pain, and fatigue. When a person develops Crestor kidney failure, their levels of protein and blood in the urine will elevate indicating serious kidney toxicity. If these symptoms of Crestor kidney failure are not diagnosed and treated earlier, they can lead to death.
Despite the serious risk of Crestor kidney failure, the manufacturer has done nothing to protect consumers from these serious health threats. If you or a loved one has developed Crestor kidney failure, or you are concerned about Crestor side effects, you may wish to contact a qualified and experienced attorney who can help determine your rights and options in a legal Crestor kidney failure personal injury lawsuit.
Need Legal Help?
Call Today: (888) 803-7598
Contact us for free information or to start a free case review.